The influence of established and new antiepileptic drugs on visual perception - II. A controlled study in patients with epilepsy under long-term antiepileptic medication

By Steinhoff B.J.   Freudenthaler N.   Paulus W.  

Epilepsy Research, Vol. 29, Iss. 1, 1997-12 ,pp. : 49-58

Elsevier

Access to resources Recommend Favorite

A Single Dose of the Serotonin Neurotransmission Agonist Paroxetine Enhances Motor Output: Double-Blind, Placebo-Controlled, fMRI Study in Healthy Subjects

By Loubinoux I.   Pariente J.   Boulanouar K.   Carel C.   Manelfe C.   Rascol O.   Celsis P.   Chollet F.  

NeuroImage, Vol. 15, Iss. 1, 2002-01 ,pp. : 26-36

Academic Press

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite